Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.
Actively Recruiting
This research aims to create a comprehensive database accessible to members of the AGAMENON - SEOM group for epidemiological and clinical research on esophageal and stomach cancer. The goal is to improve understanding of these cancers to optimize patient management, treatment, progression, and to compare data across different groups, enhancing scientific publications quality. The study is observational and collects data retrospectively from patient medical records. The study includes two groups of patients those with resectable non-advanced cancer and those with unresectable advanced cancer. Treatments recorded include surgery, chemotherapy, anti-targeted agents, immunotherapy, and radiotherapy. Data collection focuses on diagnostic and therapeutic approaches over a 12-month period. Participants information is gathered from medical records without active intervention. Researchers analyze diagnostic and treatment methods, epidemiological profiles, risk and prognostic factors, pathological features, and validate predictive models. The study spans up to 12 months for outcome measures, with participation involving no direct treatment or visits, only record review.
Actively Recruiting
This research aims to collect detailed information about patients with lung cancer and other thoracic tumors to better understand the disease and treatment outcomes. It focuses on individualizing treatment based on markers that predict response to chemotherapy and molecular inhibitors. The study addresses challenges such as poor prognosis, variability in diagnosis and treatment, and the need for improved early detection and prevention strategies across Europe and Spain. The study is observational and multicenter, gathering data both retrospectively and prospectively from patients diagnosed and treated by medical professionals including thoracic surgeons and oncologists. It includes multiple groups of patients based on the type of thoracic tumor, such as non-small cell lung cancer, small cell lung cancer, mesothelioma, thymic cancer, and carcinoid cancer. There are no experimental treatments instead, it involves comprehensive data collection on patient characteristics and treatments. Participants provide information from their medical history and treatment records over up to 10 years. Researchers study epidemiological and therapeutic factors related to thoracic tumors by reviewing clinical data. The main outcome is to describe characteristics of these tumors in Spanish patients. The study involves no interventions or medications, focusing on observation and data analysis to inform future care and research.